Dermatology · Rocky Mount, NC
NPI
1992799456
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
901 N Winstead Ave
Rocky Mount, NC, 27804
Phone (252) 937-0282
Groups this clinician bills Medicare through
Medicare paid, 2024
$277K
8,412 services
Medicare patients, 2024
1,286
Average age 77
Drug cost, 2024
$1.4M
2,052 prescriptions
Company payments, 2025
$496
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey M Suchniak was code 17003 (destruction skin lesion), 4,092 times for 615 patients. In total Jeffrey M Suchniak billed 8,412 services in 46 codes, and Medicare paid $277K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 4,092 | 615 | $4.30 | $18K |
| 17000 Destruction Skin Lesion | Office | 1,065 | 790 | $35.30 | $38K |
| 99213 Office E&M - Established | Office | 1,049 | 787 | $54.57 | $57K |
| 99214 Office E&M - Established | Office | 735 | 529 | $80.10 | $59K |
| 17110 Destruction Skin Lesion | Office | 485 | 413 | $73.67 | $36K |
| 17004 Destruction Skin Lesion | Office | 184 | 144 | $109.62 | $20K |
| 11102 Skin Biopsy | Office | 145 | 142 | $57.29 | $8,307 |
| 99212 Office E&M - Established | Office | 82 | 75 | $34.99 | $2,869 |
| 99203 Office E&M - New | Office | 69 | 69 | $68.35 | $4,716 |
| 11106 Skin Biopsy | Office | 63 | 58 | $111.68 | $7,036 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 54 | 52 | $11.19 | $604 |
| 99204 Office E&M - New | Office | 41 | 41 | $100.75 | $4,131 |
| G0008 Administration of influenza virus vaccine | Office | 37 | 37 | $27.37 | $1,013 |
| 90662 Vaccine Product | Office | 36 | 36 | $81.27 | $2,926 |
| 11104 Skin Biopsy | Office | 34 | 34 | $75.21 | $2,557 |
By year: 2022 $296K for 8,660 services; 2023 $287K for 8,733 services; 2024 $277K for 8,412 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey M Suchniak prescribed most often to Medicare patients was Ketoconazole, with 252 prescriptions and refills. In total Jeffrey M Suchniak wrote 2,052 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 252 | 267 | 135 | $5,630 |
| Clobetasol Propionate Generic | 228 | 234 | 117 | $8,336 |
| Metronidazole Generic | 192 | 199 | 97 | $12K |
| Mometasone Furoate Generic | 179 | 184 | 133 | $4,275 |
| Ciclopirox Ciclopirox Olamine | 175 | 177 | 98 | $3,126 |
| Fluocinolone Acetonide Generic | 145 | 150 | 61 | $9,673 |
| Ammonium Lactate Generic | 110 | 121 | 69 | $1,256 |
| Doxycycline Hyclate Generic | 84 | 111 | 50 | $1,053 |
| Clindamycin Phosphate Generic | 62 | 71 | 29 | $3,404 |
| Fluorouracil Generic | 36 | 36 | 24 | $3,216 |
| Hydrocortisone Generic | 35 | 35 | 29 | $418 |
| Mupirocin Generic | 34 | 34 | 33 | $258 |
| Triamcinolone Acetonide Generic | 34 | 38 | 27 | $491 |
| Fluocinonide Generic | 27 | 29 | 22 | $1,355 |
| Dupixent Pen Dupilumab | 25 | 25 | Under 11 | $100K |
Brand drugs: 165 claims; generic drugs: 1,887 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey M Suchniak $496 ($496 in general payments such as food, travel and fees) from 11 companies. The largest payer was Journey Medical Corporation with $97.33.
| Company | Payments | Amount |
|---|---|---|
| Journey Medical Corporation DERM | 1 | $97.33 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $77.57 |
| Abbvie Inc. ABBV | 4 | $76.71 |
| Genzyme Corporation SNY | 2 | $76.1 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $36.97 |
| UCB, Inc. UCB.BR | 2 | $35.52 |
| Incyte Corporation INCY | 1 | $24.75 |
| Amgen Inc. AMGN | 1 | $23.62 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $16.44 |
| LNHC, Inc | 1 | $15.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.